Tuesday, December 21, 2021

PET Scan

TECHNIQUE: Approximately 1 hour following F-18 FDG tracer injection, F-18 FDG

PET images were acquired from the base of the skull through the proximal thighs.

Noncontrast low-dose CT imaging skull base and neck, chest, abdomen, pelvis and

proximal thighs was acquired and used for F-18 FDG PET attenuation correction

and for anatomic correlation, but is not of diagnostic image quality.


FINDINGS:

F-18 FDG PET Imaging: Reference data includes a volume of right hepatic lobe

parenchyma which contains maximum SUVs of 3.6 and mean SUVs of 2.4. Superior

vena cava mediastinal blood pool SUVs are up to 2.1.


The posterior left lung subpleural pulmonary nodule measuring 0.9 x 1.2 cm

(image 107, series 2) is mildly hypermetabolic containing SUVs up to 2.4.


The previously seen very large hypermetabolic left lower lobe lung mass is no

longer present. The unenhanced CT imaging findings are compatible with interval

left lower lobe lobectomy surgery.


There is again evidence of extensive right neck surgery and photopenia of the

cervical vertebral bone marrow compatible with prior radiation therapy.


There is a very extensive very hypermetabolic skeletal metastatic pattern, with

very hypermetabolic lesions too numerous to individually describe. They involve

sites in the cervical spine, multiple thoracic vertebrae, bilateral rib

contours, all of the lumbar vertebrae and multiple sites in the pelvis and

metabolically active lesions in both proximal femurs. Examples include:


1. An osteolytic lesion in the central and right aspect of T8 vertebral body

contains SUVs up to 12.4.


2. A slightly leftward expansile osteolytic lesion the left side of L2

vertebra, measuring about 2.3 x 2.8 cm (image 168, series 3) contains SUVs up to

9.9.


3. The extensive osteolytic lesion in the S1 sacral body and left alum (image

210, series 3) contains SUVs up to 11.0.


4. Right femoral intertrochanteric proximal metaphyseal lesion contains SUVs up

to 6.8.


No additional soft tissues including lymph nodes stations detectable

hypermetabolic lesions are identified. All other sites of F-18 FDG tracer uptake

between the skull base and thighs are explainable by expected physiologic

processes including some F-18 FDG tracer localization in the left ventricular

posterolateral wall myocardium, moderate nonfocal bowel-related F-18 FDG

localization coursing through the abdomen and pelvis and evidence of excretion

of F-18 FDG tracer by the kidneys and ureter into the urinary bladder.


Other low-dose anatomic correlation CT imaging findings:


Noisy low-dose images of the brain show areas of what appear to be vasogenic

edema in the right cerebral hemisphere, involving the inferior frontal lobe

region, the frontoparietal region and especially the inferolateral right

temporal lobe. There is reduced F-18 FDG metabolic activity in the large area of

right temporal lobe radiolucency.


No metabolically active enlarged cervical lymph nodes are identified. Extensive

right neck tissue loss and numerous surgical clips also seen in the right

thoracic inlet are again noted.


The multiple osteolytic rib and thoracic spine lesions seen previously are again

noted. No additional new pulmonary nodule. The heart size is normal. No enlarged

mediastinal or hilar lymph nodes are identified and there is no evidence of

enlarged axillary lymph nodes.


The unenhanced appearance of the liver is not remarkable. The spleen size is

within normal limits measuring 11.0 cm transaxial dimension. Neither adrenal

gland contains a mass. Unenhanced appearance of the pancreas and kidneys is

unremarkable. There are no metabolically active enlarged retroperitoneal or

pelvic lymph nodes.


There is a small hiatal hernia sac. The stomach otherwise is unremarkable. Small

bowel loops are normal caliber. The colon is not remarkable.


The urinary bladder contains a small amount of fluid. The prostate gland has

dystrophic calcifications. The seminal vesicles appear symmetric.


Extensive osteolytic lesions in multiple lumbar vertebrae and in both sides of

the pelvis are noted.


IMPRESSION:


1. Previously seen large hypermetabolic left lower lobe mass is no longer

present, evidence of interval left lower lobe resection.


2. Evidence of very extensive hypermetabolic, osteolytic skeletal metastatic

pattern.


3. The small left inferoposterior lung subpleural pulmonary nodule also is

detectably metabolically active, compatible with a soft tissue metastasis.


4. Other incidental findings are similar to that seen previously.

Wednesday, December 15, 2021

The Oncologist

Dr. Shao reviewed the CT scan with Robin and me, reporting that the new lesions we must assume are cancer and that they are fast growing. The lesions are in my vertebrae and ribs, and possibly other areas of my body not scanned.

Dr. Shao will refer me to a sarcoma specialist. There may be some drug or treatment that will retard the progression of the disease but there isn’t any known path to a cancer-free future. Dr. Shao’s recommendation is to radiate areas that give me pain and try a chemo treatment to slow the cancer’s growth.

I asked him how long I have. He said in 2005 he never expected me to be in his office in 2021, all to say nobody knows about these things.

At the moment I’m in pain, my hamstring aching constantly from a mysterious injury. The next step is to get a full-body PET scan which may point the way to treating my aching leg.

Monday, December 13, 2021

CT Scan: Bad News


 Today's CT scan did not deliver the results I hoped to see. "Multiple osseous lesions are highly suspicious for metastases..."



Thursday, November 11, 2021

Surgical Pathology Report

 

There were no surprises in the report -- the tumor was synovial sarcoma as expected. I'm continuing to put all information on the blog as a backup of medical records. Some of our friends are physicians too, so if I can get free medical analysis I'll take it.




Monday, November 1, 2021

Second Operation

The second operation took place Saturday. The tumor was attached to the lung and chest wall so there was more lung resection and removal of tissue from the chest. The incision was the same as the last time, the surgeon opening the chest at the same place.

It’s Monday afternoon as I write this, happy to be out of the hospital. This time around I didn’t need the opiates as much as before and so feel more clearheaded. I have a variety of pain-management drugs which should work just fine.

I’m hoping to be back on my feet in a few months and looking forward to going skiing. I’m so happy to be home. A hospital stay makes sitting on the couch watching television seem like a luxury vacation.    

Monday, October 11, 2021

Radiation Oncologist: Surgical Option Best

I spoke with a radiation oncologist today (telemedicine!). All the doctors agree. The next step should be an operation to remove the tumor.

The consultation was informative in that stereotactic body radiation therapy (SBRT) can be helpful in treating sarcomas – but it is still the second choice after surgery.

Surgical Consultation #2


The meeting with the surgeon Dr. Kai Engstad went well in that he saw no reason not to recommend surgery – his remarks are above. This means that a cancer-free future is still possible.  

Engstad warned the complexity of the operation is higher than before because the tumor is in a region that was recently operated on. Scar tissue, flesh reconstituting after disruption, can make for tricky going. Also, the difficulty of the procedure may be increased depending on what surfaces the tumor has adhered to. There is no way to know these finer points without opening me up.

Although Dr. Shao has said that this type of cancer, synovial sarcoma, can not be treated with radiation, I will consult with a radiation oncologist. This is to understand thoroughly what radiation can do in this case. If there is no significant benefit, Dr. Engstad would prefer to skip radiation as this would create more irregular surfaces in the area to be excised.

My main fear is that these surgical procedures become a game of whack-a-mole. The thought I had 16 years between bouts of cancer makes me optimistic I can have another good run.

Many people have acknowledged the difficulty of this period for me and my family. I am so very grateful to receive words of support and empathy. I am comforted that I am part of a web of significant relationships that have defined and enhanced my life. I hope that by posting the details of my cancer treatment here I can skip recounting them in conversation. I don’t know if I will live a long or short time, but either way I prefer to minimize the black thoughts and try and find a positive headspace. So much is unknowable.

I will have a telemedicine consultation with the radiation oncologist later today. As always, I will post all information here.

Tuesday, October 5, 2021

Bad News

Last week I had a CT scan which indicated a new spot of cancer. Today I met with Dr. Shao, the oncologist, to understand the path forward.

The new tumor is in a cluster of lymph nodes near to where the last tumor resided, nestled between the lung and the heart. The only permanent treatment for synovial sarcoma is surgical, radiation and chemotherapy will just delay growth or mildly shrink the tumor.

The treatment options are ranked from best downward.

  • Excise the tumor with a minimally invasive surgery;
  • Excise the tumor by opening the chest to gain access;
  • If no surgical option is viable, try and retard growth with radiation.

I am scheduling the surgical consultation and will post any news here.

For those who are interested, here is the analysis of the CT scan.



Monday, August 2, 2021

Three-month Checkup

I had my three-month checkup after the surgery. I had hoped to get a final verification that all was well, but such was not to be.

The scan indicates a blood clot and a nodule. The nodule is new and may be just the result of the surgery. There will be another scan in three months.  

Despite this worrisome news, I have been feeling well lately. My lung has stopped hurting when I inhale and, after recent chiropractic treatments, the ache in my ribs eased. When I do normal activity, I feel like my regular self. I notice the diminished lung capacity when I exercise but this is minor in the scope of things.

For those who want the technical stuff, here it is: 

CLINICAL DATA: History of sarcoma.

COMPARISON STUDY: CT chest, abdomen, and pelvis with contrast 3/12/2021.

TECHNIQUE: Sequential axial images of the chest were obtained following a
helical acquisition and intravenous contrast administration of nonionic
contrast. Radiation dose reduction techniques were used.

FINDINGS:

CHEST WITH CONTRAST:
SUPERIORMOST ABDOMEN: The visualized portions of the superiormost abdominal
visceral organs are unremarkable except for 1.1 cm hypodense spleen lesion,
image 98.
MEDIASTINUM: The heart and great vessels of mediastinum are unremarkable except for thrombus in a posterior branch of the left lower lobe pulmonary artery along the course of the surgical staple line. No other pulmonary artery filling defects are identified. Soft tissue density node or nodule is seen in the left anterior lateral mediastinum abutting the pericardium, 1.2 x 1.5 cm with Hounsfield density units of 32, image 55. Otherwise there is no mediastinal or
hilar adenopathy nor pericardial effusion.


TRACHEA AND CENTRAL BRONCHI: The large airways are clear.

LUNGS: There is mild bilateral apical pleural-parenchymal opacity compatible with scarring. Two tiny nodules are seen in the Right Lower Lobe: 4 mm, image 67 and 3 mm, image 79. A 3 mm nodule seen in the Left Upper Lobe lateral, image 38. There are postsurgical changes partial Left Lower Lobe resection with surgical staple line and associated bandlike opacity in the left inferior posterior medial chest extending to the pleura where there is trace pleural fluid and pleural gas bubble, image 80.
PLEURA AND PLEURAL SPACE: There is no pleural effusion or pneumothorax.
MUSCULOSKELETAL: Unremarkable.

IMPRESSION:
1. Postsurgical changes of partial Left Lower Lobe resection with surgical staple line/bandlike opacity and thrombus within a posterior branch of the Left Lower Lobe pulmonary artery extending to the surgical staple line/bandlike opacity. No other evidence of pulmonary embolus.
2. Left anterior mediastinal node or nodule 1.3 x 1.5 cm, metastatic disease is in the differential, appears new from 3/12/2021, alternatively may be postsurgical change/reactive lymph node. RECOMMEND close interval surveillance with CT of the chest with contrast in three months.
3. Trace left pleural fluid and pleural gas bubble left inferior posterior chest.

Monday, May 17, 2021

No Additional Cancer Detected So Far

The pathology report from tissue taken during the surgery has shown no cancer in the tumor’s margins or in the sampled lymph nodes. Also negative were samples taken from pleuritic fluid.  

This supports the idea that the tumor was the only spot of cancer and no further treatment may be required.

I am happy and relieved. 



Saturday, May 15, 2021

Home, Sweet Home

 

I’m happy to report that all went well in the surgery. No surprises, bad reactions, or undetected landmines. The tumor was removed intact with decent margins.

To my delight, I was discharged on the earlier side of the spectrum. Obviously, the wound needed to begin the healing process, but I also credit early release on presenting a compelling vision of recuperation to the medical staff.

I told the doctors that I envisioned sitting on the couch with my wife, under a blanket, watching our favorite news program on television, with the possibility of a cat on top of the blanket. The doctors weren’t cat aficionados but understood, mentioning this concept approvingly several times as I was being discharged.

I’m home feeling optimistic about the future. In several weeks there will be more scans and decisions about treatment. Until I hear otherwise, I will follow the plan, which is believing that all is under control and this bout of cancer will soon fade into the past.

Thank you for your concern and well wishes!





Wednesday, May 12, 2021

Surgery Today

LBJ showing off the scar from his gall bladder surgery in 1965. 

The above is a reminder that there will be no similar pictures of myself posted here – this is a safe space.

Today is the surgery and I look forward to reporting on the successful operation when I return home in several days.

Portland friends, there is no hospital visitation allowed (besides Robin) due to COVID so I will catch up with you afterwards.

Be well!


Tuesday, April 27, 2021

The Big Reveal


Today I met with Dr. Engstad, the surgeon who will operate on me in a few weeks. After many different tests and scans, he concluded that the lower lobe of my left lung will need to be removed.

Although I will be losing 25% of my lung capacity, he said that after a year of healing and rehabilitation I might only be down 10% as the human body has excess lung capacity. Hiking, biking, skiing should still be on the table and I don’t yet need to recalibrate with birdwatching.

This certainly was good news, a huge sigh of relief, that there is a best possible outcome that has me doing the activities that I love. Still, I need to prepare for the chance that radiation or some other treatment might be necessary, and nothing is a sure thing.

Dr. Engstad stressed that unlike more common cancers, where patterns of recurrence and metastasis are well known, the behavior of sarcomas is little understood. Was the original sarcoma in my neck connected to this new one? Why had sarcoma been dormant for 15 years? Where was it hiding? Where to look for any new outbreaks?

He talked about how there is a randomness to medicine as well as other aspects of life, as the medical profession declares one “cured” after 5 years of regular cancer scans. How did the doctors arrive at the 5-year number? “Five fingers, five toes,” he said.

The operation itself will not require a massive incision. The item of concern that will keep me hospitalized is how long it will take for the wound to stop leaking air. Generally the time is 3-6 days. Afterwards a few months of taking it easy and then the work of rehabilitation.

Before this diagnosis I had the aspirational philosophy of not taking the relationships in my life for granted. Illness certainly sharpens that feeling many times over. I want to give everyone a big hug in gratitude for all the good energy sent our way. I will continue to post significant milestones on this blog but expect that after the operation things will not be happening so fast.

Thanks for reading and I hope to see you in person soon.

Tuesday, April 20, 2021

SURGICAL PATHOLOGY CONSULT REPORT

Study Result

Narrative

FLAMM, ERIC S Age: 55 years 
Collected Date: 3/26/2021 08:50 PDT 
ADM Consult
CONSULT DIAGNOSIS
Left lung mass, biopsy (Mayo No. CR-21-19309):
- Metastatic synovial sarcoma.
ANCILLARY STUDIES
Immunohistochemistry for TLE1 shows nuclear expression in the spindled cells but not in glands.
Report electronically signed by: Andrew L. Folpe, M.D.
Mayo Clinic Laboratories, Department of Pathology
200 First Street SW, Rochester, MN 55905
04/06/2021 10:25 Mitchell R Ryan, MD
MTM/MRR (Electronic Signature)
.
.
Consult Comment
I have reviewed the slides representing a biopsy of a left lung mass from the above patient
with a history of a reportedly monophasic synovial sarcoma of the retropharynx and entirely agree with you that this specimen shows metastatic synovial sarcoma. It is somewhat difficult to say whether this represents a monophasic synovial sarcoma with a very exuberant proliferation of non-neoplastic epithelium or a biphasic synovial sarcoma. I would somewhat favor biphasic synovial sarcoma on morphologic grounds although TLE1 expression in biphasic synovial sarcomas is usually confined to the epithelium, in contrast to what is seen here. Ultimately, the distinction between monophasic and biphasic synovial sarcoma is really of no clinical concern, as there are no known differences in behavior or response to therapy in monophasic versus biphasic tumors or in synovial sarcomas having different fusion subtypes.
Thank you for sharing this case with me. If you have any questions, please do not hesitate to
reach me by calling Mayo Clinic Laboratories at 1-800-533-1710.
Material Received
A. SG-21-0001608: Left lung mass
1 stained slide, 1 block
1 CD
Surgical Pathology Report
DIAGNOSIS
Diagnosis After Microscopic Examination:
Left lung mass, needle core biopsy:
- Diagnosis PENDING outside consultation.
- See Comments.
03/29/2021 14:00 Mitchell R Ryan, MD
MJC/MRR (Electronic Signature)
.
.
Pathology processing and professional performed at Legacy Central Lab,
services
1225 NE Second Ave Portland, OR unless otherwise specified.
Cytology and HPV technical and professional performed at Legacy Central Lab,
services
1225 NE Second Ave Portland, OR unless otherwise specified.
FLAMM, ERIC S Age: 55 years MRN: 800048-83-73
Collected Date: 3/26/2021 08:50 PDT Case Number: SG-21-0001608
Comments
We understand this patient had a monophasic synovial sarcoma excised from the retropharynx in
2005 (surgical pathology case SE-05-2796). We also understand the patient had a noninvasive
high-grade, urothelial carcinoma of the bladder diagnosed in 2019 (surgical pathology case
SG-19-3978). The current biopsy shows a biphasic neoplasm with spindled and epithelioid
components, and extensive necrosis. The histology resembles biphasic synovial cell sarcoma.
Given the limited material present to work with, and that genetic studies may be required
for definitive diagnosis, material will be referred for expert consultative opinion, with the
consultant's diagnosis and findings to be reported in an addendum.
MR/mjc
Microscopic
Provision of Service: Professional Services Provided by Cascade Pathology Services, 24800 SE
Stark Street, Gresham, OR 97030.
Specimen
Left lung mass
Clinical Information
Lung mass. History of bladder cancer and sarcoma
Gross Description
Received in formalin labeled " Flamm, Eric" and "left lung mass" are multiple tan-gray to
tan-pink
needle core fragments ranging in size from less than 0.1 up to 0.6 cm in greatest
dimension.
TE1A,1B.
MDM/bb
Pathology processing and professional performed at Legacy Central Lab,
services
1225 NE Second Ave Portland, OR unless otherwise specified.
Cytology and HPV technical and professional performed at Legacy Central Lab,
services
1225 NE Second Ave Portland, OR unless otherwise specified.

Wednesday, April 14, 2021

PFT COMPLETE 1 (PRE-POST+DLCO+TLC)

 I have little idea what this test means to my treatment. Still, I promised to post all data so here it is. This is where the doctors who know stuff loom large and look like heroes.

Component Results

ComponentYour ValueStandard Range
FVC PRE BR3.32 L
FVC PRE%PRED BR68 %
FVC POST BR3.32 L
FVC POST % PRED BR68 %
FVC % CHANGE BR0 %
FVC LLN3.73 L
FEV1 PRE BR2.61 L
PFT FEV1 PRE % PRED BR69 %
FEV1 POST BR2.75 L
FEV1 POST % PRED BR73 %
FEV1 % CHANGE BR5 %
FEV1 LLN2.89 L
FEV1/FVC % PRE BR79 %
FEV1/FVC PRE%PRED100 %
FEV1/FVC % POST BR83 %
PFT FEV1/FVC POST%PRED105 %
FEV1/FVC %CHANGE5 %
FEV1/FVC LLN67 %
FRC PL PRE BR3.17 L
FRC PL % PRED PRE BR88 %
FRC PL LLN2.16 L
RV PRE BR2.09 L
RV % PRED PRE B97 %
RV PL LLN1.39 L
TLC PRE BR5.06 L
TLC % PRED PRE BR72 %
TLC LLN5.39 L
RV/TLC PL PRE41 %
RV/TLC % PRE B132 %
RV/TLC PL LLN22 %
DLCO PRE BR23.35 ml/min/mmHg
DLCO % PRED PRE BR81 %
DLCO UNC LLN20.24 ml/min/mmHg
DLCO PRE COR25.63 ml/min/mmHg
DLCO COR PRED PRE89 %
DLCO COR LLN20.24 ml/min/mmHg
HGB DLCO


 


11.8 gm/dL